BEMTUVIQ

Swiss trademark · 833774 · Combined mark · In force

Register entry

Registration number
833774
Application number
10177/2025
Status
In force
Type
Combined mark
As registered
BEMTUVIQ ((fig.))
Filed
Jul 11, 2025
Registered
Jul 18, 2025
Published
Jul 18, 2025
Protected until
Jul 11, 2035
Language of procedure
German
Vienna classes
25.05.01, 25.05.03, 26.04.04, 26.04.09, 26.04.24
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen zur Behandlung von Krebs sowie von Herz-Kreislauf-Erkrankungen und -Störungen; pharmazeutische Präparate und Substanzen zur Behandlung von onkologischen Erkrankungen und onkologischen Störungen; pharmazeutische Präparate zur Behandlung von Magen- und gastroösophageale Erkrankungen oder Beschwerden.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 18, 2025

    Registered

    Published in Swissreg on 18.07.2025

Parties

Holder

Amgen Inc.

AMGEN INC.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Agent

WEINMANN ZIMMERLI

Carmenstrasse 28, 8032 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.